Link Between Sodium Intake, Cardiovascular Health Examined

Share this content:
Link Between Sodium Intake, Cardiovascular Health Examined
Link Between Sodium Intake, Cardiovascular Health Examined

(HealthDay News) — The association between sodium intake and cardiovascular outcomes is complex, according to three studies published online in the New England Journal of Medicine.

Andrew Mente, PhD, from McMaster University in Hamilton, Canada, and colleagues examined the relationship between electrolyte excretion and blood pressure (BP) in 102,216 adults from 18 countries. 

The researchers found that for each 1-g increment in estimated sodium excretion there were increments of 2.11 mm Hg and 0.78 mm Hg in systolic and diastolic BP, respectively. Higher sodium intake correlated with a steeper slope for this association, as did hypertension and increased age.

Martin O'Donnell, PhD, also from McMaster University, and colleagues examined the estimated urinary sodium and potassium excretion and a composite outcome of death and major cardiovascular (CV) events for 101,945 individuals from 17 countries. 

The researchers found that an estimated sodium excretion higher than the reference range of 4.00 to 5.99 g per day correlated with increased risk for the composite outcome (OR=1.15). Increased risk for the composite outcome was also seen for estimated sodium excretion below 3.00 g per day (OR=1.27). 

In a third modeling study, Dariush Mozaffarian, MD, DrPH, from Tufts University in Boston, and colleagues estimated that sodium consumption above a reference level of 2.0 g per day contributed to 1.65 million deaths from CV causes that occurred in 2010.

"Taken together, these three articles highlight the need to collect high-quality evidence on both the risks and benefits of low-sodium diets," wrote the authors of an accompanying editorial.

Several researchers from the Mente study disclosed financial ties to the pharmaceutical industry. The Mente and O'Donnell studies were partially funded by grants from pharmaceutical companies.

References

  1. Mente A et al. N Engl J Med. 2014;371:601-611.
  2. O'Donnell M et al. N Engl J Med. 2014;371:612-623.
  3. Mozzaffarian D et al. N Engl J Med. 2014;371:624-634.
  4. Oparil S et al. N Engl J Med. 2014;371:677-679.
You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus